---
figid: PMC9531712__gr3
pmcid: PMC9531712
image_filename: gr3.jpg
figure_link: /pmc/articles/PMC9531712/figure/f0015/
number: Fig. 3
figure_title: ''
caption: 'Porcupine Inhibitors Have Multiple Effects on Tumor BiologyDC: Dendritic
  cells, MDSC: myeloid-derived suppressor cells. T-reg: regulatory T-cells. Image
  created with BioRender.com.'
article_title: Targeting ligand-dependent wnt pathway dysregulation in gastrointestinal
  cancers through porcupine inhibition.
citation: Dustin J. Flanagan, et al. Pharmacol Ther. 2022 Oct;238:None-None.
year: '2022'

doi: 10.1016/j.pharmthera.2022.108179
journal_title: Pharmacology & Therapeutics
journal_nlm_ta: Pharmacol Ther
publisher_name: Pergamon Press

keywords:
- Porcupine inhibitor
- Wnt
- gastrointestinal cancer
- RNF43
- RSPO
- clinical trials
- APC, adenomatous polyposis coli
- CAF, cancer associated fibroblast
- CMS, consensus molecular subtype
- CRC, colorectal cancer
- CSC, cancer stem cell
- EMT, epithelial-mesenchymal transition
- Dkk, Dickkopf
- HCC, hepatocellular carcinoma
- LGR, leucine-repeat G-coupled receptor
- LRP, low-density lipoprotein receptor-related protein
- MSI, microsatellite instability
- PCP, planar cell polarity
- ROR, receptor tyrosine kinase-like orphan receptors
- RSPO, R-spondin
- SFRP, Secreted frizzled-related protein
- TP53, transformation-related protein 53

---
